The oral squamous cell carcinoma (OSCC) 5 year survival rate of 41% has marginally
improved in the last few years, with less than a 1% improvement per year from 2005 to 2017 …

Human papillomavirus (HPV) related oropharyngeal squamous cell carcinoma (OPSCC) is
associated with improved outcomes compared to non-virally mediated disease. Clinical …

Importance Circulating tumor tissue–modified viral (TTMV) human papillomavirus (HPV)
DNA is a dynamic, clinically relevant biomarker for HPV-positive oropharyngeal squamous …

Background Development of evidence‐based post‐treatment surveillance guidelines in
recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) is limited by …

Tumor cells release fragments of their DNA into the circulation, so called cell‐free tumor
DNA (ctDNA), allowing for analysis of tumor DNA in a simple blood test, that is, liquid biopsy …

Importance Human papillomavirus (HPV)–positive oropharyngeal squamous cell carcinoma
has an overall favorable prognosis, yet a subset of patients will experience devastating …

Purpose: Observational studies suggest circulating tumor human papillomavirus (HPV) DNA
may facilitate early detection of recurrent HPV-positive oropharynx cancer. We prospectively …

Simple Summary Circulating human papillomavirus DNA is a promising tool in the
management of HPV-positive oropharyngeal cancer. The potential use of this tool will …

Human papillomavirus (HPV) infections are the primary cause of almost all cervical cancers,
anal cancers, and a variable proportion of other anogenital tumors, as well as head and …

The global incidence of human papillomavirus–positive (HPV+) head and neck squamous
cell carcinoma (HNSCC) has surged in recent decades, with HPV+ HNSCC accounting for> …